SEARCH

SEARCH BY CITATION

References

  • ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother., 14, 4858.
  • BACON, W.L. & BECK, S.G. (2000). 5-Hydroxytryptamine7 receptor activation decreases slow afterhyperpolarization amplitude in CA3 hippocampal pyramidal cells. J. Pharmacol. Exp. Ther., 294, 672679.
  • BARD, J.A., ZGOMBICK, J., ADHAM, N., VAYSSE, P., BRANCHEK, T.A. & WEINSHANK, R.L. (1993). Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J. Biol. Chem., 268, 2342223426.
  • BELENKY, M.A. & PICKARD, G.E. (2001). Subcellular distribution of 5-HT1B and 5-HT7 receptors in the mouse suprachiasmatic nucleus. J. Compar. Neurol., 432, 371388.
  • BOESS, F.G. & MARTIN, I.L. (1994). Molecular biology of 5-HT receptors. Neuropharmacology, 33, 275317.
  • CHAPIN, E.M. & ANDRADE, R. (2001). A 5-HT7 receptor-mediated depolarization in the anterodorsal thalamus. I. Pharmacological characterization. J. Pharmacol. Exp. Ther., 297, 395402.
  • COHEN, Z., BOUCHELET, I., OLIVIER, A., VILLEMURE, J.G., BALL, R., STANIMIROVIC, D.B. & HAMEL, E. (1999). Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: molecular and pharmacologic characterization. J. Cereb. Blood Flow Metabol., 19, 908917.
  • EGLEN, R.M., JASPER, J.R., CHANG, D.J. & MARTIN, G.R. (1997). The 5-HT7 receptor: orphan found. Trends Pharmacol. Sci., 18, 104107.
  • ELLIOTT, J.M., NEWBERRY, N.R., CHOLEWINSKI, A.J., BARTRUP, J.T., BRIDDON, S.J., CAREY, J.E., FLANIGAN, T.P., NEWTON, R.A., PHIPPS, S.L., REAVLEY, A.C., SMITH, C., WIGMORE, M., GRAHAME-SMITH, D.G. & LESLIE, R.A. (1995). Characterization of the 5-hydroxytryptamine2A receptor-activated cascade in rat C6 glioma cells. Neuroscience, 69, 11191131.
  • GILL, C.H., SOFFIN, E.M., HAGAN, J.J. & DAVIES, C.H. (2002). 5-HT7 receptors modulate synchronized network activity in rat hippocampus. Neuropharmacology, 42, 8292.
  • GOAILLARD, J.M. & VINCENT, P. (2002). Serotonin suppresses the slow afterhyperpolarization in rat intralaminar and midline neurones by activating 5-HT7 receptors. J. Physiol., 541, 453465.
  • HAGAN, J.J., PRICE, G.W., JEFFREY, P., DEEKS, N.J., STEAN, T., PIPER, D., SMITH, M.I., UPTON, N., MEDHURST, A.D., MIDDLEMISS, D.N., RILEY, G.J., LOVELL, P.J., BROMIDGE, S.M. & THOMAS, D.R. (2000). Characterization of SB-269970-A, a selective 5-HT7 receptor antagonist. Br. J. Pharmacol., 130, 539548.
  • HEIDMANN, D.E.A., METCALF, M.A., KOHEN, R. & HAMBLIN, M.W. (1997). Four 5-hydroxytryptamine7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron–exon organization. J. Neurochem., 68, 13721381.
  • HIRST, W.D., PRICE, G.W., RATTRAY, M. & WILKIN, G.P. (1997). Identification of 5-hydroxytryptamine receptors positively coupled to adenylyl cyclase in rat cultured astrocytes. Br. J. Pharmacol., 120, 509515.
  • HOYER, D., CLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, F.R. & HUMPHREY, P.P.A. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46, 157203.
  • HUNEYCUTT, B.S. & BENVENISTE, E.N. (1995). Regulation of astrocyte cell biology by the cAMP/protein kinase A signaling pathway. Adv. Neuroimmunol., 5, 261269.
  • JASPER, J.R., KOSAKA, A., TO, Z.P., CHANG, D.J. & EGLEN, R.M. (1997). Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7(b)). Br. J. Pharmacol., 122, 126132.
  • KROBERT, K.A., BACH, T., SYVERSVEEN, T., KVINGEDAL, A.M. & Levy, F.O. (2001). The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution. Naunyn-Schmiedeberg's Arch. Pharmacol., 363, 620632.
  • LOVELL, P.J., BROMIDGE, S.M., DABBS, S., DUCKWORTH, D.M., FORBES, I.T., JENNINGS, A.J., KING, F.D., MIDDLEMISS, D.N., RAHMAN, S.K., SAUNDERS, D.V., COLLIN, L.L., HAGAN, J.J., RILEY, G.J. & THOMAS, D.R. (2000). A novel, potent, and selective 5-HT7 antagonist: (R)-3-(2-(2-(4-methylpiperin-1-yl)-ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970). J. Med. Chem., 43, 342345.
  • LOVENBERG, T.W., BARON, B.M., DE LECEA, L., MILLER, J.D., PROSSER, R.A., REA, M.A., FOYE, P.E., RACKE, M., SLONE, A.L., SIEGEL, B.W., DANIELSON, P.E., SUTCLIFFE, J.G. & ERLANDER, M.G. (1993). A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron, 11, 449458.
  • MEYERHOF, W., OBERMÜLLER, F., FEHR, S. & RICHTER, D. (1993). A novel rat serotonin receptor: primary structure, pharmacology, and expression pattern in distinct brain regions. DNA Cell Biol., 12, 401409.
  • PLASSAT, J.L., AMLAIKI, N. & HEN, R. (1993). Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. Mol. Pharmacol., 44, 229236.
  • RANSOM, B., BEHAR, T. & NEDERGAARD, M. (2003). New roles for astrocytes (stars at last). Trends Neurosci., 26, 520522.
  • RUAT, M., TRAIFFORT, E., LEURS, R., TARDIVEL-LACOMBE, J., DIAZ, J., ARRANG, J.M. & SCHWARTZ, J.-C. (1993). Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc. Natl. Acad. Sci. U.S.A., 90, 85478551.
  • SCHOEFFTER, P., BOBIRNAC, I., BODDEKE, E. & HOYER, D. (1997). Inhibition of cAMP accumulation via recombinant human serotonin 5-HT1A receptors: considerations on receptor effector coupling across systems. Neuropharmacology, 36, 429437.
  • SCHOEFFTER, P., FEUERBACH, D., BOBIRNAC, I., GAZI, L. & LONGATO, R. (1999). Functional, endogenously expressed corticotropin-releasing factor receptor type 1 (CRF1) and CRF1 receptor mRNA expression in human neuroblastoma SH-SY5Y cells. Fund. Clin. Pharmacol., 13, 484489.
  • SCHOEFFTER, P., ULLMER, C., BOBIRNAC, I., GABBIANI, G. & LÜBBERT, H. (1996). Functional, endogenously expressed 5-hydroxytryptamine 5-ht7 receptors in human vascular smooth muscle cells. Br. J. Pharmacol., 117, 993994.
  • SHEN, Y., MONSMA JR, F.J., METCALF, M.A., JOSE, P.A., HAMBLIN, M.W. & SIBLEY, D.R. (1993). Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J. Biol. Chem., 268, 1820018204.
  • SHIMIZU, M., NISHIDA, A., ZENSHO, H. & YAMAWAKI, S. (1996). Chronic antidepressant exposure enhances 5-hydroxytryptamine7 receptor-mediated cyclic adenosine monophosphate accumulation in rat frontocortical astrocytes. J. Pharmacol. Exp. Ther., 279, 15511558.
  • THOMAS, D.R. & HAGAN, J.J. (2004). 5-HT7 receptors. Curr. Drug Targets CNS Neurol. Disord., 3, 8190.
  • TO, Z.P., BONHAUS, D.W., EGLEN, R.M. & JAKEMAN, L.B. (1995). Characterization and distribution of putative 5-ht7 receptors in guinea-pig brain. Br. J. Pharmacol., 115, 107116.
  • TSOU, A.P., KOSAKA, A., BACH, C., ZUPPAN, P., YEE, C., TOM, L., ALVAREZ, R., RAMSEY, S., BONHAUS, D.W., STEFANICH, E., JAKEMAN, L., EGLEN, R.M. & CHAN, H.W. (1994). Cloning and expression of a 5-hydroxytryptamine7 receptor positively coupled to adenylate cyclase. J. Neurochem., 63, 456464.
  • YING, S.W. & RUSAK, B. (1997). 5-HT7 receptors mediate serotonergic effects on light-sensitive suprachiasmic nucleus neurons. Brain Res., 755, 246254.